Skip to content

Fyodor Biotechnologies

500 Global GA 22 · Developer of a non-invasive malaria testing technology designed to deliver a simple system to major global health problems.

Competitors

Adjacent

Also from 500 Global GA 22

All of 500 Global GA 22

Programs

Programs Fyodor Biotechnologies went through
ProgramCohortSource
500 GlobalGA 22 · 2018500 Global Page

About Fyodor Biotechnologies

Developer of a non-invasive malaria testing technology designed to deliver a simple system to major global health problems. The company's technology helps people with a fever to diagnose malaria using a few drops of urine instead of blood, enabling healthcare professionals to help patients diagnose malaria conveniently and minimize pain and blood loss.

Category
Other
Location
United States
Checked
2h ago

Tags: Health Tech

Fyodor Biotechnologies: questions

Which accelerators did Fyodor Biotechnologies go through?

Fyodor Biotechnologies is listed by 500 Global (Global GA 22).

Where is Fyodor Biotechnologies based?

Fyodor Biotechnologies lists United States as its location on 500 Global's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.